SYNGENE price chart
Daily close · 5-year history
Instrument details
Identifiers & classification
- Symbol
- SYNGENE
- MB Code
- MBEQU2649
- ISIN
- INE398R01022
- BSE code
- 539268
- Industry group
- Healthcare Services
- Screener
- View peers →
Latest earnings
Most recent declared quarter
- Quarter
- Mar 2026
- Revenue
- 1036.5 Cr
- Net profit
- 147.9 Cr
- EPS
- 3.67
- YoY revenue
- +1.82%
Company documents
12 PDFs across 4 categories
Audited annual reports & financial statements
Earnings call transcripts & Q&A
Investor decks & strategy updates
Exchange filings & corporate announcements
Corporate timeline
Earnings, news & corporate actions for SYNGENE
Dividend of ₹1.25 per share
Ex-date corporate action
On April 30, Syngene shares jumped up to 10% after Q4FY26 results: revenue +1.8% YoY to ₹1,037 cr, net profit -19.3% to ₹147.9 cr; Macqua…
EPS 3.82 vs est. 1.95
Beat estimates by 96.08%
Syngene International shares fell 15% in two sessions, marking a nine-session losing streak with a total decline of 20%. The company's Q3…
EPS 2.70 vs est. 2.44
Beat estimates by 10.76%
Syngene International has extended its research partnership with Bristol Myers Squibb until 2035, enhancing collaboration in drug develop…
Syngene International shares rose 3.6% on January 7, 2026, after Macquarie maintained an 'outperform' rating with a target price of ₹835,…
EPS 1.67 vs est. 2.14
Missed estimates by 22.04%
Price returns
Historical performance
Technicals
Indicator consensus